Pharmaceutical agent for the treatment of cachexia and / or cardiogenic shock

摘要

The invention relates to an agent for the treatment of cachexia due to chronic cardiac insufficiency, cirrhosis of the liver, chronic obstructive lung disease or chronic kidney insufficiency and/or cardiogenic shock. Said agent contains an effective amount of an immunosuppressive substance or a mixture of such substances and makes possible a new therapeutic method for weight loss therapy following a disease (cachexia) and for therapy of cardiogenic shock (severe decompensation after acute myocardial infarct).